Research Topics
Species | Esteban MartinezSummaryAffiliation: Infectious Diseases Unit Country: Spain Publications
| Collaborators
|
Detail Information
Publications
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patientsEsteban Martinez
Hospital Clinic, Barcelona, Spain
AIDS 21:367-9. 2007..In contrast, abacavir showed a lower incidence of adverse effects leading to drug discontinuation...
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravirEsteban Martinez
Hospital Clinic IDIBAPS, Universitat de Barcelona, 08036 Barcelona, Spain
AIDS Res Hum Retroviruses 29:235-41. 2013..2744). The results of this analysis do not suggest that outcomes of abacavir/lamivudine are worse than those of tenofovir/emtricitabine when combined with raltegravir in virologically suppressed HIV-infected adults...
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravirEsteban Martinez
Hospital Clinic IDIBAPS, Universitat de Barcelona, Spain
AIDS 26:2315-26. 2012..Switching from boosted protease inhibitors (PI/r) to raltegravir (RAL) results in a better plasma lipid profile than continuing PI/r. Whether this strategy affects plasma biomarkers associated with atherosclerosis is unknown...
Effectiveness of lipid-lowering therapy in HIV patientsEsteban Martinez
Infectious Diseases Unit, IDIBAPS Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain
Curr Opin HIV AIDS 3:240-6. 2008..The aim of this article is to analyse the effectiveness of lipid-lowering therapy in HIV-infected patients...
Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patientsPaula Freitas
Endocrinology, Diabetes and Metabolism Department of Centro Hospitalar São João, E P E, University of Porto Medical School, Alameda Hernani Monteiro, 4200 319 Porto, Portugal
BMC Infect Dis 11:246. 2011..This study aimed to evaluate the prevalence of the metabolic syndrome (MS) and its components, and to determine whether patients with or without CL had a different prevalence of MA...
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parametersEsteban Martinez
Infectious Diseases Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, C Villarroel 170, 08036 Barcelona, Spain
AIDS 24:353-63. 2010..To assess the effects of decreased antiretroviral therapy exposure on body fat and metabolic parameters...
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunctionEsteban Martinez
Infectious Diseases Unit, Hospital Clinic Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, C Villarroel 170, 08036 Barcelona, Spain
AIDS 24:F1-9. 2010..To assess the effects of initiating abacavir-containing therapy on plasma lipids and cardiovascular biomarkers...
Cardiovascular disease and HIV infection: host, virus, or drugs?Esteban Martinez
Infectious Diseases Unit, Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain
Curr Opin Infect Dis 22:28-34. 2009..We review the risk of cardiovascular disease in HIV-infected persons compared with that in uninfected persons and discuss the relative contributions of host, HIV, and antiretroviral therapy in the light of current knowledge...
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppressionEsteban Martinez
Hospital Clinic Institut d Investigaciones Biomediques August Pi i Sunyer, University of Barcelona, 08036 Barcelona, Spain
J Acquir Immune Defic Syndr 51:290-7. 2009..We compared 48-week efficacy and safety of these combinations as substitutes of nucleosides in patients with virological suppression...
Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavirEsteban Martinez
Hospital Clinic Institut d Investigaciones Biomediques August Pi i Sunyer, Valencia, Spain
Clin Infect Dis 38:1017-23. 2004..These findings may have clinical implications when the therapeutic option of lopinavir-ritonavir is considered...
Objective amount of limb fat in HIV-infected subjects with subjective diagnosis of lipoatrophyE Martinez
Infectious Diseases Unit, Hospital Clinic Institut d Investigaciones Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
HIV Med 10:257-61. 2009..The relationship between the subjective diagnosis of lipoatrophy and the objective amount of limb fat loss in HIV-infected adults is unclear...
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical areaE Martinez
Infectious Diseases Unit, Institut d Investigacions Biomediques August Pi i Sunyer, Hospital Clinic Universitari, Barcelona, Spain
HIV Med 8:251-8. 2007....
[Lipid profile of atazanavir]Esteban Martínez Chamorro
Servicio de Infecciones, Hospital Clinic Institut d Investigaciones Biomediques August Pi i Sunyer, Universidad de Barcelona, Espana
Enferm Infecc Microbiol Clin 26:34-40. 2008....
Retroviruses and opportunistic infections - 13th annual meetingEsteban Martinez
University of Barcelona, Infectious Diseases Unit, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain
IDrugs 9:250-2. 2006
The reassurance of experienceE Martinez
Infectious Diseases Unit, Hospital Clinic IDIBAPS, Barcelona, Spain
Int J STD AIDS 14:20-8. 2003..Stavudine has a low incidence of clinically significant adverse events, and those experienced are generally long-term, manageable class effects...
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitorsEsteban Martinez
Hospital Clinic IDIBAPS, Barcelona, Spain
Antivir Ther 8:403-10. 2003..Whether a therapeutic approach addressed to those metabolic abnormalities may have any impact on body fat is not clear...
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infectionEsteban Martinez
Infectious Diseases Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
N Engl J Med 349:1036-46. 2003..We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a protease inhibitor in patients infected with human immunodeficiency virus type 1 (HIV-1) in whom virologic suppression had been achieved...
Disorders of fat partitioning in treated HIV-infectionEsteban Martinez
Infectious Diseases Unit, Hospital Clinic Institut d Investigaciones Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
Best Pract Res Clin Endocrinol Metab 25:415-27. 2011..Surgical filling cosmetically improves facial lipoatrophy. Exercise and diet may reduce increased visceral adipose tissue. Liposuction may be useful to remove superficial, localized fat accumuli...
Influenza A H1N1 in HIV-infected adultsE Martinez
Infectious Diseases Unit, Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain
HIV Med 12:236-45. 2011..We aimed to compare epidemiological data, clinical characteristics, and outcomes of influenza A H1N1 infection between HIV-infected and -uninfected adults...
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL studyEsteban Martinez
Infectious Diseases Unit, Hospital Clínic Institut d Investigaciones Biomèdiques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
AIDS 24:1697-707. 2010..Switching to raltegravir in selected patients treated with ritonavir-boosted protease inhibitors may result in similar efficacy and lower plasma lipids...
Simplification of antiretroviral therapy with etravirineEsteban Martinez
Infectious Diseases Unit, Hospital Clinic, University of Barcelona IDIBAPS, Barcelona, Spain
AIDS Rev 12:52-9. 2010..Long-term trials are necessary to confirm the role of etravirine in simplification strategies, but preliminary clinical data is reassuring...
The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patientsAna Milinkovic
Infectious Diseases Unit, Hospital Clinic Barcelona, Barcelona, Spain
Antivir Ther 12:407-15. 2007..We assessed the safety and efficacy of reducing the dose of stavudine compared with switching to tenofovir or maintaining the standard dose of d4T...
Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapineAgathe Leon
Infectious Diseases Unit, Hospital Clinic, University of Barcelona, Spain
AIDS 19:213-5. 2005..These results argue against the use of tenofovir plus didanosine in HIV-infected antiretroviral-naive adults even when the third drug is a non-nucleoside reverse transcriptase inhibitor...
Mitochondrial effects of antiretroviral therapies in asymptomatic patientsSonia Lopez
Muscle Research Unit, Department of Internal Medicine, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute IDIBAPS, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain
Antivir Ther 9:47-55. 2004..A decrease in the mitochondrial (mt) DNA to nuclear DNA ratio has gained acceptance as a marker of mitochondrial toxicity in treated HIV-infected patients, but the functional meaning of this alteration is unclear...
Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirinMontserrat Laguno
Infectious Diseases Service, Hospital Clinic Universitari de Barcelona, Barcelona, Spain
J Acquir Immune Defic Syndr 44:174-8. 2007..Few data are available in HIV/HCV-coinfected patients, however...
Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patientsMontserrat Laguno
Infectious Diseases Unit, Hospital Clinic, Villarroel, 170, Barcelona, Spain
AIDS Res Hum Retroviruses 24:547-53. 2008..Despite the high prevalence, this phenomenon does not seem to affect the clinical evolution of chronic hepatitis C or modify the viral response to interferon-based HCV therapies..
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP studyJosep Mallolas
Hospital Clinic Universitari IDIBAPS, University of Barcelona, Barcelona, Spain
J Acquir Immune Defic Syndr 51:29-36. 2009..To evaluate the efficacy and safety of switching from boosted lopinavir (LPV/r) to boosted atazanavir (ATV/r) in virologically suppressed HIV-1-infected patients versus continuing LPV/r...
High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovirAgathe Leon
Infectious Diseases Unit, Hospital Clinic, University of Barcelona, Spain
AIDS 19:1695-7. 2005..These results argue against the use of tenofovir-didanosine not only in naive patients, but also in previously suppressed patients...
Antiretroviral activity of didanosine in patients with different clusters of reverse transcriptase mutationsJose Luis Blanco
Infectious Diseases Unit, University of Barcelona, Spain
AIDS 20:1891-2. 2006..0152) or thymidine-associated (P = 0.0142) mutations. In conclusion, ddI retained substantial antiretroviral activity when the number of nucleoside-associated or thymidine-associated mutations was less than four...
Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovirMaria Saumoy
Infectious Disease Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
Antivir Ther 16:459-68. 2011....
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patientsMaria Larrousse
Infectious Diseases Unit, Hospital Clínic Universitari de Barcelona IDIBAPS, University of Barcelona, Spain
J Acquir Immune Defic Syndr 46:304-11. 2007..Several serum markers reflecting extracellular matrix status have been correlated with liver fibrosis in non-HIV-infected patients with chronic hepatitis C infection. These indexes have been less examined in HIV/HCV-coinfected individuals...
In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosisOscar Miro
Mitochondrial Research Laboratory, Hospital Clinic, IDIBAPS, Barcelona, Catalonia, Spain
Antivir Ther 10:945-51. 2005....
Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adultsEsteban Martinez
Infectious Diseases Unit, Hospital Clinic, University of Barcelona, Calle Villarroel 170, 08036 Barcelona, Spain
Lancet 364:65-7. 2004..666, 95% CI 1.246-91.294, p=0.031). These results suggest that the risk of pancreatitis is heightened when didanosine and tenofovir are given together...
Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosineOscar Miro
Mitochondrial Research Laboratory, Muscle Research Unit, Department of Internal Medicine, Hospital Clinic, Institut d Investigations Bioiuèdiques August Pi I Sunyer, Barcelona, Spain
J Acquir Immune Defic Syndr 37:1550-5. 2004..These data suggest that upregulatory transcriptional or posttranscriptional mechanisms compensate for mtDNA depletion caused by d4T + ddI before profound mtDNA depletion occurs...
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitorJose L Blanco
Infectious Diseases Service, IDIBAPS, Hospital Clinic, Faculty of Medicine, University of Barcelona, Barcelona, Spain
AIDS 19:829-31. 2005..Only one of the 66 patients developed changes in their pattern of mutations able to generate or increase resistance to new drugs...
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumptionAgathe Leon
Infectious Diseases Department, Hospital Clinic of Barcelona, Villarroel 170, 08036 Barcelona, Spain
J Antimicrob Chemother 63:184-8. 2009..CD4+ T cell recovery dynamics were analysed during the 'on treatment' periods in structured therapy interruption (STI) as well as the long-term immune reconstitution with highly active antiretroviral therapy (HAART) after finishing STI...
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell countFelipe Garcia
Clinic Institute of Infectious Diseases and Immunology, IDIBAPS, Hospital Clinic, Faculty of Medicine, University of Barcelona, Spain
J Acquir Immune Defic Syndr 36:702-13. 2004..It seems that the immune recovery slows down after approximately 3 years of HAART and reaches a plateau after 4-5 years of HAART...
Association between physical and echographic fat thickness assessments and a lipodystrophy grading scale in lipodystrophic HIV patients: practical implicationsVictor Asensi
Infectious Diseases Unit, Hospital Central de Asturias, Oviedo University School of Medicine, Barcelona, Spain
AIDS Res Hum Retroviruses 22:830-6. 2006..The combination of these subjective and objective parameters could be helpful in the early detection of lipodystrophy in clinical practice...
Low rate of sustained virological response in an outbreak of acute hepatitis C in HIV-infected patientsMontserrat Laguno
Infectious Diseases, University of Barcelona, Spain
AIDS Res Hum Retroviruses 28:1294-300. 2012..There is a risk of sexual transmission of HCV in HIV-infected men who have sex with men. In our experience, early treatment of AHC with pegylated interferon-alfa plus ribavirin in HIV patients achieves poor results...
[Current status of acute hepatitis C]María Martínez-Rebollar
Servicio de Infecciones, Hospital Clinic, Barcelona, Espana
Enferm Infecc Microbiol Clin 29:210-5. 2011..The optimal treatment regimen (interferon alone or combined with ribavirin) and its duration are not clearly established at the present time...
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trialAdrian Curran
Infectious Diseases Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
Antivir Ther 17:711-8. 2012....
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruptionGabriel Mestre
Infectious Diseases Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, University of Barcelona, Barcelona, Spain
AIDS Res Hum Retroviruses 24:1485-95. 2008..This finding suggests that STI could decrease the number of NK subsets, which is related to the worst clinical development in these patients...
Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemiaGloria Garrabou
Mitochondrial Research Laboratory, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona and CIBER de Enfermedades Raras, CIBERER, Barcelona, Spain
J Acquir Immune Defic Syndr 52:443-51. 2009....
Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitisMarylène Lejeune
Immunology Service, Hospital Clinic Institut d Investigacions Biomèdiques Augustí Pi i Suñer, University of Barcelona, Barcelona, Spain
Clin Infect Dis 52:662-70. 2011..It is unknown whether a Toxoplasma gondii-specific T cell response is restored after successful combined antiretroviral therapy (cART) in patients with AIDS and current or previous toxoplasmic encephalitis (TE)...
Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAARTConstanza Moren
Mitochondrial Functionalism Laboratory, Universitat de Barcelona, IDIBAPS, Hospital Clinic, Barcelona, Spain
Antivir Ther 16:719-24. 2011..We aimed to determine whether mtDNA and mitochondrial function abnormalities are present in peripheral blood mononuclear cells from asymptomatic HIV-infected children...
Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adultsElena Ferrer
HIV Unit, Service of Infectious Diseases, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
AIDS Res Hum Retroviruses 27:1061-5. 2011..008) and subcutaneous fat (42%, p = 0.008). These data suggest that switching from LPV/r to ATV/r is associated with increased trunk fat, both subcutaneous and visceral...
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretroviralsOscar Miro
Mitochondrial Research Laboratory, Muscle Research Unit, Department of Internal Medicine, Hospital Clinic, Villarroel 170, 08036 Barcelona, Catalonia, Spain
Clin Infect Dis 39:710-6. 2004..001), along with increased lipid peroxidation of PBMC membranes (P=.007). Therefore, HIV infection is associated not only with mtDNA depletion, but also with extensive MRC disturbances and increased oxidative damage...
Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1Jordi Blanch
Clinical Institute of Psychiatry and Psychology, Hospital Clinic Universitari de Barcelona, 08036 Barcelona, Spain
Clin Infect Dis 38:1464-70. 2004..Specific characteristics of patients, antiretroviral-based side effects, and breast lipoaccumulation exert a greater impact on QoL in HIV-1-infected patients with LD...
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscleOscar Miro
Mitochondrial Research Laboratory, Muscle Research Unit, Department of Internal Medicine, Hospital Clinic, IDIBAPS, Barcelona, Catalonia, Spain
AIDS Res Hum Retroviruses 21:702-5. 2005..We conclude that skeletal muscle of HIV-infected patients exhibits increased apoptosis compared with that of uninfected patients, but the role of HAART in inducing apoptosis remains to be established...
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patientsMontse Laguno
Infectious Diseases Unit, Hospital Clinic Barcelona, Barcelona, Spain
Antivir Ther 10:423-9. 2005....
Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant womenMaría Martínez-Rebollar
Infectious Diseases Service, IDIBAPS, Hospital Clinic, Barcelona, Spain
Ther Drug Monit 33:772-7. 2011..No vertical transmissions were reported. Therapeutic drug monitoring of SQV during pregnancy should be considered, mainly during the third trimester, to ensure adequate drug exposure throughout the entire pregnancy...
Mitochondrial damage in adipose tissue of untreated HIV-infected patientsGloria Garrabou
Mitochondrial Research Laboratory, Internal Medicine Department, Muscle Research Unit, IDIBAPS, University of Barcelona, Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Raras, Spain
AIDS 25:165-70. 2011..However, the viral capacity to induce adipose tissue mitochondrial lesion is still a matter of doubt. We aimed to assess whether untreated HIV infection was associated with adipose tissue mitochondrial abnormalities...
Use of diet, nutritional supplements and exercise in HIV-infected patients receiving combination antiretroviral therapies: a systematic reviewPere Leyes
Nutrition and Dietetics Unit, Endocrinology Service, Hospital Clinic de Barcelona, 08036 Barcelona, Spain
Antivir Ther 13:149-59. 2008..Nutritional status could influence body composition changes...
Improvement of psychosocial adjustment to HIV-1 infection through a cognitive-behavioral oriented group psychotherapy program: a pilot studyAraceli Rousaud
Fundació Clínic per la Recerca Biomèdica IDIBAPS, Institut d Investigacions Biomèdiques Agustí Pi i Sunyer, Hospital Clinic de Barcelona, Barcelona, Spain
AIDS Patient Care STDS 21:212-22. 2007..Our psychotherapy program improved psychosocial functioning in a heterogeneous sample of HIV-1-infected patients referred to a consultation-liaison psychiatry unit...
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapyEsteban Martinez
Infectious Diseases, Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain
Antivir Ther 9:649-63. 2004..Development of new PIs with more favourable effects on the lipid profile should be of benefit...
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudyAdrian Curran
Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Infectious Diseases Department, Spain
AIDS 26:475-81. 2012..To compare 48-week changes in body fat distribution and bone mineral density (BMD) between patients switching from a ritonavir-boosted protease inhibitor (PI/r) to raltegravir (RAL) and patients continuing with PI/r...
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis CMontserrat Laguno
Infectious Diseases Unit, Hospital Clinic Universitari de Barcelona, Barcelona, Spain
Antivir Ther 9:905-9. 2004..In this study, we evaluated the incidence and management of depressive symptoms during IFN-alpha therapy in HIV-infected patients with CHC...
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized studyAgathe Leon
Infectious Diseases Unit, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
PLoS ONE 6:e14515. 2011..This clinical scenario requires a new approach to simplify follow-up appointments and facilitate access to healthcare professionals...
Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trialJose M Miro
Institut d Investigacions Biomediques August Pi Sunyer Hospital Clinic, University of Barcelona, Barcelona, Spain
Clin Infect Dis 43:79-89. 2006..To our knowledge, no randomized trials have evaluated whether prophylaxis against toxoplasmic encephalitis can be safely discontinued after the CD4+ T cell count increases in response to highly active antiretroviral therapy...
Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophyJordi P Guallar
Department of Biochemistry and Molecular Biology and Institut de Biomedicina IBUB, University of Barcelona, and CIBER Fisiopatología de Obesidad y Nutrición, Instituto de Salud Carlos III, Barcelona, Spain
AIDS 22:575-84. 2008..To elucidate the molecular basis of the progressive enlargement of dorso-cervical adipose tissue, the so-called 'buffalo hump', that appears in a sub-set of patients with HIV-1/HAART-associated lipodystrophy...
A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular riskMar Masia
Department of Clinical Medicine, Infectious Diseases Unit, Hospital General Universitario de Elche, University Miguel Hernandez, Elche, Alicante, Spain
J Antimicrob Chemother 64:589-98. 2009..We evaluated the efficacy and safety of an intensive versus a standard intervention in HIV-infected patients with moderate-high cardiovascular risk...
Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapyVictor Asensi
Infectious Diseases Unit, Hospital Central de Asturias, Oviedo University School of Medicine, Celestino Villamil s n, 33004 Oviedo, Spain
Clin Infect Dis 39:240-7. 2004..Echographically measured PRFD is associated with lipodystrophy and could be used as an early predictor of this syndrome in treatment-naive patients starting HAART...
Switching to raltegravir in virologically suppressed in HIV-1-infected patients: a retrospective, multicenter, descriptive studyDaniel Podzamczer
Infectious Disease Service, Hospital Universitari de Belvitge, L Hospitalet de Llobregat, Barcelona, Spain
Curr HIV Res 10:673-8. 2012..To describe the efficacy and tolerability of switching to raltegravir (RAL) in virologically suppressed HIV-1-infected patients during routine clinical practice...
Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patientsAlba Diaz
Department of Pathology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
AIDS 24:2029-39. 2010..The factors associated with fibrosis in lymphoid tissue in long-term treated HIV-infected patients and their correlation with immune reconstitution were assessed...
Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapyOscar Miro
Mitochondrial Research Laboratory, Department of Internal Medicine, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute IDIBAPS, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain
AIDS Res Hum Retroviruses 19:1027-32. 2003..Mitochondrial abnormalities had almost disappeared later when the patient became asymptomatic. Our findings support the hypothesis that MRC dysfunction stands at the basis of HAART-related hyperlactatemia...
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003)Omar Sued
Servicios de Enfermedades Infecciosas, , , Universidad de Barcelona, Villaroel 170, 08036 Barcelona, Spain
Enferm Infecc Microbiol Clin 24:238-44. 2006..HAART given during primary HIV infection was effective, but was associated with a high percentage of adverse effects...
Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adultsEsteban Martinez
Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, University of Barcelona, E 08036 Barcelona, Spain
Clin Infect Dis 35:130-9. 2002..For patients with concurrent meningitis, high doses of cefotaxime could be used if the MIC for cefotaxime was < or =1 microg/mL. Early recognition of heart failure and surgery may help to decrease mortality...
Impact of lipodystrophy on the quality of life of HIV-1-infected patientsJordi Blanch
Clinical Institute of Psychiatry and Psychology, Hospital Clinic Universitari de Barcelona, Barcelona, Spain
J Acquir Immune Defic Syndr 31:404-7. 2002..Lipodystrophy (LD) represents an important problem for HIV-1-infected patients receiving highly active antiretroviral therapy (HAART), although its impact on quality of life (QoL) has not been properly studied...
Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxisFelipe Garcia
Infectious Diseases Unit, University of Barcelona, Barcelona, Spain
Antivir Ther 7:195-7. 2002..This antiretroviral regimen seems to have no effect on lymphocyte T cell subsets, however, it could have an immune-modulator role, inducing an increase in the proliferative responses to mitogens...
Polymorphic receptors of the innate immune system (MBL/MASP-2 and TLR2/4) and susceptibility to pneumococcal bacteremia in HIV-infected patients: a case-control studyJuan P Horcajada
Infectious Diseases Service, Hospital Clinic Universitari de Barcelona, Barcelona, Spain
Curr HIV Res 7:218-23. 2009..In HIV infected patients, no association between the presence of deficient polymorphisms of MBL2, MASP2, TLR2 and TLR4 and the incidence of pneumococcal bacteremia was found...
Assessing the long-term viability of facial fat grafts: an objective measure using computed tomographyJoan Fontdevila
Department of Plastic Surgery, Hospital Clinic, University of Barcelona, Barcelona, Spain
Aesthet Surg J 28:380-6. 2008..Autologous fat transplantation for soft tissue augmentation is a commonly used technique without a universally accepted approach. The literature includes a variety of reports describing varying degrees of success or failure...
Current perspectives on HIV-associated lipodystrophy syndromeAna Milinkovic
Clinical Institute of Infections and Immunology, Institu d Investigacions Biomédiques August Pi i Sunyer, Hospital Clinic, Barcelona, Spain
J Antimicrob Chemother 56:6-9. 2005..The issue of body composition has become extremely important for the adequate management of HIV-infected patients...
Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapyPere Domingo
Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
AIDS Rev 14:112-23. 2012..In the context of HIV-1-infected patients under long-term antiretroviral therapy, fat toxicity is still the dark side of the rainbow...
Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAARTOriol Coll
Clinica Eugin, IDIBAPS, University of Barcelona, Barcelona, Spain
AIDS 20:121-3. 2006..Subclinical hypogonadism mediated by immunosuppression may explain these observations, suggesting the need to optimize the immunological status of the patient before considering assisted reproduction treatments...
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapyPilar Navarrete
Infectious Diseases Unit, Clinic Institute of Infectious Diseases and Immunology, Faculty of Medicine, University of Barcelona, Barcelona, Spain
Antivir Ther 8:635-7. 2003..No correlation was observed after 1 year of antiretroviral therapy. A protease inhibitor-containing regimen was the best predictor of good tonsillar tissue virological response...
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsMontserrat Laguno
Infectious Diseases Unit, the Pathology Service, , University of Barcelona, Spain
AIDS 18:F27-36. 2004..565). CONCLUSION: PEG-INF + RBV was significantly more effective than INF + RBV for the treatment of chronic hepatitis C in HIV co-infected patients, mainly of genotype 1 or 4...
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapyAnna Suy
Obstetric and Gynecological Service, Hospital Clinic of the Institute of Biomedical Investigations, August Pi i Sunyer Hospital, University of Barcelona, Barcelona, Spain
AIDS 20:59-66. 2006..183; 95% CI, 0.054-0.627; P = 0.007) were risk factors in HIV-infected women. CONCLUSIONS: HIV infection treated with HAART prior to pregnancy was associated with a significantly higher risk for pre-eclampsia and fetal death...
Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control studyAlejandra Biglia
Infectious Diseases Unit, Hospital Clinic-Institut d'Investigaciones Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain
Clin Infect Dis 39:1514-9. 2004..8-32.2; P=.003) were independent factors associated with gynecomastia. CONCLUSIONS: The data suggest that gynecomastia among HIV-infected patients is related to hypogonadism, rather than to an adverse effect of antiretroviral drugs...
Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophyGiovanni Guaraldi
Universita di Modena e Reggio Emilia, Modena, Italy
Antivir Ther 12:1059-65. 2007..Both psychological and organic factors have been recognized to be associated with sexual dysfunction in HIV-infected individuals...
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavirAnna Ochoa de Echaguen
Hospital Mutua de Terrassa, Terrassa, Spain
AIDS 19:1385-91. 2005....
Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapyTimothy W Schacker
Department of Medicine, University of Minnesota, MMC 250, 516 Delaware Street, Minneapolis MN 55455, USA
J Infect Dis 186:1092-7. 2002....
The NEFA study: results at three yearsEsteban Martinez
AIDS Rev 9:62. 2007
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational studyCristina Mussini
Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy
Clin Infect Dis 38:565-71. 2004..Recurrent cryptococcal infection should be suspected in patients whose serum cryptococcal antigen test results revert back to positive after discontinuation of maintenance therapy...
The role of viruses in the aetiology of community-acquired pneumonia in adultsMaria Angeles Marcos
Department of Microbiology, Hospital Clinic i Provincial de Barcelona, Spain
Antivir Ther 11:351-9. 2006..We aimed to study the incidence and clinical characteristics of community-acquired pneumonia (CAP) due to respiratory viruses in adults adding PCR to routine conventional laboratory tests...
Prevention strategies for cardiovascular disease in HIV-infected patientsJames H Stein
Circulation 118:e54-60. 2008
